Hamsyl

Component, content:

Dosage form, administration:

Solution. For IM/IV Administration

Indications:
(a) Indicated as a component of multi agent chemotherapeutic regimen for the treatment of
patients with acute lymphoblastic leukemia who are hypersensitive to asparaginase
(b) Pegaspargase injection as First-Line chemotherapeutic agent for treatment of patients
with acute lymphoblastic leukemia (ALL).